Skip to main content
. 2015 Oct 23;10(10):e0141351. doi: 10.1371/journal.pone.0141351

Table 2. MRE-SNPs from the filtered set of associations that overlap with validated miRNA-target interactions.

MRE-SNP Effect a Allele MAF b Gene MeanZ-score c miRNA Seed Conservation d AGO e Context+change miRSVR miRandascore Validation f Ref Type g
rs10187 D C/T 0.06 ISCU 13.39 miR-210-3p 8mer mammals + -0.55 -1.10 154 IM/EX/QP [44] C
LU/QP/WE [45]
CL [46]
rs4245739* C A/C 0.32 MDM4 18.27 miR-191-5p 7mer-m8 no - -0.32 -0.61 155 LU [47] C
rs17765088 D C/G 0.13 CCR9 4.79 miR-335-5p 8mer mammals - -0.29 -0.33 153 EX [48] U
rs3828609 D T/C 0.15 CSF1R 17.91 miR-155-5p 8mer mammals - -0.28 -1.01 148 EX [49] U
rs2239680* D T/C 0.26 BIRC5 8.62 miR-335-5p 7mer-m8 no + -0.26 -0.63 157 LU [50] U
rs1048077 D G/A 0.34 ENPP4 12.00 miR-103a-3p 8mer no + -0.19 n.a. 147 SE [51] U
rs1056801 D T/C 0.08 SEPT2 3.88 miR-20a-5p 8mer primates + -0.11 -1.01 149 CL [46] C
miR-17-5p 8mer primates + -0.10 -1.02 146 CL [46] C
rs8614 D C/A 0.11 NUFIP2 4.01 miR-365a-3p 8mer vertebrates + -0.08 -0.02 169 CL [46] C
15.20 C
rs2241201 D C/G 0.24 MMAB 4.40 miR-335-5p 7mer-m8 no - -0.08 -0.02 143 EX [48] U
rs2341984 C C/T 0.25 SLC6A6 10.58 miR-423-5p 8mer no - -0.07 -0.01 156 CL [46] U
rs2151511 C G/A 0.48 MTG2 7.66 miR-769-5p 7mer-m8 mammals - -0.07 -0.01 144 CL [46] U
rs710100 C G/A 0.39 TNFAIP2 6.68 miR-155-5p 7mer-A1 primates - 0.04 -0.01 149 PS [52] U
rs17759843 C G/A 0.09 PPM1F 10.31 miR-186-5p 7mer-m8 primates - 0.08 n.a. 152 CL [46] U
rs4679372 D A/G 0.29 ZNF148 20.39 miR-186-5p 7mer-m8 primates - 0.13 n.a. 156 SE [51] C

* SNP has been experimentally shown to influence MRE.

a SNP effect on miRNA binding: D disrupts an MRE and C creates an MRE.

b MAF is based on 1000G pilot 1 CEU population.

c Z-scores from a recent eQTL meta-analysis [21] are averaged for LD block (R2 = 1, 1000G pilot 1, CEU); FDR < 0.05 for all associations.

d Conservation shows in which species a corresponding MRE is present (polymiRTS v3.0 database).

e Supported by AGO-CLIP data.

f Validation method: LU- luciferase reporter assay; IM- immunoprecipitation; EX- target expression profiling; CL- CLASH; QP- qRT-PCR; SE- sequencing; PS- pSiLAC; and WE- Western blot.

g Association type: C-concordant; U-unconcordant.